Cargando…
Promising Antibacterial and Antifungal Agents Based on Thiolated Vitamin K3 Analogs: Synthesis, Bioevaluation, Molecular Docking
In the present study, we designed and synthesized thiolated VK3 analogs (VK3a–g) along with an extensive antimicrobial study. After the evaluation of the antibacterial and antifungal activity against various bacterial and fungal strains, we presented an initial structure–activity relationship study...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146127/ https://www.ncbi.nlm.nih.gov/pubmed/35631412 http://dx.doi.org/10.3390/ph15050586 |
_version_ | 1784716484064313344 |
---|---|
author | Yıldırım, Hatice Yıldız, Mahmut Bayrak, Nilüfer Mataracı-Kara, Emel Radwan, Mohamed Osman Jannuzzi, Ayse Tarbin Otsuka, Masami Fujita, Mikako TuYuN, Amaç Fatih |
author_facet | Yıldırım, Hatice Yıldız, Mahmut Bayrak, Nilüfer Mataracı-Kara, Emel Radwan, Mohamed Osman Jannuzzi, Ayse Tarbin Otsuka, Masami Fujita, Mikako TuYuN, Amaç Fatih |
author_sort | Yıldırım, Hatice |
collection | PubMed |
description | In the present study, we designed and synthesized thiolated VK3 analogs (VK3a–g) along with an extensive antimicrobial study. After the evaluation of the antibacterial and antifungal activity against various bacterial and fungal strains, we presented an initial structure–activity relationship study on these VK3 analogs. In particular, four thiolated VK3 analogs exhibited superior biological potency against some Gram-positive bacterial strains, including Staphylococcus aureus (ATCC(®) 29213) and Enterococcus faecalis (ATCC(®) 29212). Next, all thiolated VK3 analogs were evaluated for their potential of cell growth inhibition on the NCI-60 cancer cell lines panel. This screening underlined that the thiolated VK3 analogs have no visible cytotoxicity on different cancer cell lines. The selected two thiolated VK3 analogs (VK3a and VK3b), having minimal hemolytic activity, which also have the lowest MIC values on S. aureus and E. faecalis, were further evaluated for their inhibition capacities on biofilm formation after evaluating their potential in vitro antimicrobial activity against each of the 20 clinically obtained resistant strains of Staphylococcus aureus. VK3b showed excellent antimicrobial activity against clinically resistant S. aureus isolates. Furthermore, the tested molecules showed nearly two log(10) reduction in the viable cell count at six hours according to the time kill curve studies. Although these molecules decreased biofilm attachment about 50%, when sub-MIC concentrations were used these molecules increased the percentage of biofilm formation. The molecular docking of VK3a and VK3b in S. aureus thymidylate kinase was conducted in order to predict their molecular interactions. VK3a and VK3b exhibited excellent lead-likeness properties and pharmacokinetic profiles that qualify them for further optimization and development. In conclusion, since investigating efficient novel antimicrobial molecules is quite difficult, these studies are of high importance, especially in the present era of antimicrobial resistance. |
format | Online Article Text |
id | pubmed-9146127 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91461272022-05-29 Promising Antibacterial and Antifungal Agents Based on Thiolated Vitamin K3 Analogs: Synthesis, Bioevaluation, Molecular Docking Yıldırım, Hatice Yıldız, Mahmut Bayrak, Nilüfer Mataracı-Kara, Emel Radwan, Mohamed Osman Jannuzzi, Ayse Tarbin Otsuka, Masami Fujita, Mikako TuYuN, Amaç Fatih Pharmaceuticals (Basel) Article In the present study, we designed and synthesized thiolated VK3 analogs (VK3a–g) along with an extensive antimicrobial study. After the evaluation of the antibacterial and antifungal activity against various bacterial and fungal strains, we presented an initial structure–activity relationship study on these VK3 analogs. In particular, four thiolated VK3 analogs exhibited superior biological potency against some Gram-positive bacterial strains, including Staphylococcus aureus (ATCC(®) 29213) and Enterococcus faecalis (ATCC(®) 29212). Next, all thiolated VK3 analogs were evaluated for their potential of cell growth inhibition on the NCI-60 cancer cell lines panel. This screening underlined that the thiolated VK3 analogs have no visible cytotoxicity on different cancer cell lines. The selected two thiolated VK3 analogs (VK3a and VK3b), having minimal hemolytic activity, which also have the lowest MIC values on S. aureus and E. faecalis, were further evaluated for their inhibition capacities on biofilm formation after evaluating their potential in vitro antimicrobial activity against each of the 20 clinically obtained resistant strains of Staphylococcus aureus. VK3b showed excellent antimicrobial activity against clinically resistant S. aureus isolates. Furthermore, the tested molecules showed nearly two log(10) reduction in the viable cell count at six hours according to the time kill curve studies. Although these molecules decreased biofilm attachment about 50%, when sub-MIC concentrations were used these molecules increased the percentage of biofilm formation. The molecular docking of VK3a and VK3b in S. aureus thymidylate kinase was conducted in order to predict their molecular interactions. VK3a and VK3b exhibited excellent lead-likeness properties and pharmacokinetic profiles that qualify them for further optimization and development. In conclusion, since investigating efficient novel antimicrobial molecules is quite difficult, these studies are of high importance, especially in the present era of antimicrobial resistance. MDPI 2022-05-10 /pmc/articles/PMC9146127/ /pubmed/35631412 http://dx.doi.org/10.3390/ph15050586 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Yıldırım, Hatice Yıldız, Mahmut Bayrak, Nilüfer Mataracı-Kara, Emel Radwan, Mohamed Osman Jannuzzi, Ayse Tarbin Otsuka, Masami Fujita, Mikako TuYuN, Amaç Fatih Promising Antibacterial and Antifungal Agents Based on Thiolated Vitamin K3 Analogs: Synthesis, Bioevaluation, Molecular Docking |
title | Promising Antibacterial and Antifungal Agents Based on Thiolated Vitamin K3 Analogs: Synthesis, Bioevaluation, Molecular Docking |
title_full | Promising Antibacterial and Antifungal Agents Based on Thiolated Vitamin K3 Analogs: Synthesis, Bioevaluation, Molecular Docking |
title_fullStr | Promising Antibacterial and Antifungal Agents Based on Thiolated Vitamin K3 Analogs: Synthesis, Bioevaluation, Molecular Docking |
title_full_unstemmed | Promising Antibacterial and Antifungal Agents Based on Thiolated Vitamin K3 Analogs: Synthesis, Bioevaluation, Molecular Docking |
title_short | Promising Antibacterial and Antifungal Agents Based on Thiolated Vitamin K3 Analogs: Synthesis, Bioevaluation, Molecular Docking |
title_sort | promising antibacterial and antifungal agents based on thiolated vitamin k3 analogs: synthesis, bioevaluation, molecular docking |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146127/ https://www.ncbi.nlm.nih.gov/pubmed/35631412 http://dx.doi.org/10.3390/ph15050586 |
work_keys_str_mv | AT yıldırımhatice promisingantibacterialandantifungalagentsbasedonthiolatedvitamink3analogssynthesisbioevaluationmoleculardocking AT yıldızmahmut promisingantibacterialandantifungalagentsbasedonthiolatedvitamink3analogssynthesisbioevaluationmoleculardocking AT bayraknilufer promisingantibacterialandantifungalagentsbasedonthiolatedvitamink3analogssynthesisbioevaluationmoleculardocking AT mataracıkaraemel promisingantibacterialandantifungalagentsbasedonthiolatedvitamink3analogssynthesisbioevaluationmoleculardocking AT radwanmohamedosman promisingantibacterialandantifungalagentsbasedonthiolatedvitamink3analogssynthesisbioevaluationmoleculardocking AT jannuzziaysetarbin promisingantibacterialandantifungalagentsbasedonthiolatedvitamink3analogssynthesisbioevaluationmoleculardocking AT otsukamasami promisingantibacterialandantifungalagentsbasedonthiolatedvitamink3analogssynthesisbioevaluationmoleculardocking AT fujitamikako promisingantibacterialandantifungalagentsbasedonthiolatedvitamink3analogssynthesisbioevaluationmoleculardocking AT tuyunamacfatih promisingantibacterialandantifungalagentsbasedonthiolatedvitamink3analogssynthesisbioevaluationmoleculardocking |